Literature DB >> 15851749

Neuropathy resembling CIDP in patients receiving tumor necrosis factor-alpha blockers.

C Richez1, P Blanco, A Lagueny, T Schaeverbeke, J Dehais.   

Abstract

Tumor necrosis factor-alpha (TauNuFalpha) blockers are effective in the treatment of inflammatory arthritis but can induce autoimmune disorders including multiple sclerosis. Described are two patients who developed chronic inflammatory demyelinating polyneuropathy after initiation of anti-TNFalpha treatment.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15851749     DOI： 10.1212/01.WNL.0000158681.29117.8B

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  19 in total

1.  Neurological complications of biologic therapy in psoriasis: a review.

Authors:  Mark Bechtel; Catherine Sanders; Ann Bechtel
Journal:  J Clin Aesthet Dermatol       Date:  2009-11

Review 2.  Imaging spectrum of immunomodulating, chemotherapeutic and radiation therapy-related intracranial effects.

Authors:  Christie M Lincoln; Peter Fata; Susan Sotardi; Michael Pohlen; Tomas Uribe; Jacqueline A Bello
Journal:  Br J Radiol       Date:  2017-11-03       Impact factor: 3.039

3.  Investigation of effects of two-different treatment modalities on nerve conduction in patients with ankylosing spondylitis.

Authors:  Erhan Capkin; Murat Karkucak; Muammer Muslim Kose; Vildan Altunayoğlu Çakmak; Aysegul Kucukali Turkyilmaz; Mehmet Tosun
Journal:  Rheumatol Int       Date:  2010-12-01       Impact factor: 2.631

Review 4.  Monoclonal antibody therapy-associated neurological disorders.

Authors:  Xavier Bosch; Albert Saiz; Manuel Ramos-Casals
Journal:  Nat Rev Neurol       Date:  2011-01-25       Impact factor: 42.937

Review 5.  Neurological adverse events associated with anti-tumor necrosis factor α treatment.

Authors:  Antonio G Tristano
Journal:  J Neurol       Date:  2010-05-22       Impact factor: 4.849

6.  Oculomotor nerve palsy associated with bortezomib in a patient with multiple myeloma: a case report.

Authors:  Bassem Toema; Hamdan El-Sweilmeen; Tarek Helmy
Journal:  J Med Case Rep       Date:  2010-10-26

Review 7.  Update on medication-induced peripheral neuropathy.

Authors:  Louis H Weimer; Noor Sachdev
Journal:  Curr Neurol Neurosci Rep       Date:  2009-01       Impact factor: 5.081

Review 8.  Neurological disorders and inflammatory bowel diseases.

Authors:  Giovanni Casella; Gian Eugenio Tontini; Gabrio Bassotti; Luca Pastorelli; Vincenzo Villanacci; Luisa Spina; Vittorio Baldini; Maurizio Vecchi
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 9.  Status of immune mediators in painful neuropathies.

Authors:  Nurcan Uçeyler; Claudia Sommer
Journal:  Curr Pain Headache Rep       Date:  2008-06

10.  Soluble Tumor Necrosis Factor Receptor 1 Released by Skin-Derived Mesenchymal Stem Cells Is Critical for Inhibiting Th17 Cell Differentiation.

Authors:  Fang Ke; Lingyun Zhang; Zhaoyuan Liu; Sha Yan; Zhenyao Xu; Jing Bai; Huiyuan Zhu; Fangzhou Lou; Wei Cai; Yang Sun; Yuanyuan Gao; Hong Wang; Honglin Wang
Journal:  Stem Cells Transl Med       Date:  2016-01-27       Impact factor: 6.940
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.